dm+d
409391006
Medicine Compliance Aid Stability
MimparaAmgen Ltd
Amgen Ltd
Mimpara
Tablets f/c 30mg, 60mg, 90mg
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
No special precautions for storage
Nil relevant.
7 November 2022
Lactation Safety Information
Low levels anticipated in milk due to the drug's properties
No published evidence of safety
Monitor infant’s calcium levels if maternal treatment is prolonged
22 September 2020